About this trial
The goal of this observational study is to learn about the analgesic efficacy and postoperative recovery of two locoregional anesthesia combinations in patients \> 18 years (ASA I-III), scheduled for unilateral TKA under spinal anesthesia with expected hospitalization \> 24 hours:
* ACB + sacral ESP block * ACB + iPACK block
The main question it aims to answer is: Does the ACB + sacral ESP block combination produce effective postoperative recovery and analgesic effect?
Participants already taking ACB + sacral ESP block as part of their regular peri-operative care for TKA will be followed in the postoperative period for 48 hours.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults >18 years
ASA I-III
scheduled for unilateral TKA with expected hospitalization > 24 hours
Disqualifiers
Refusal of consent
Local anesthetics allergies
contraindications to spinal or regional anesthesia
coagulation disorders
Trial population
Adults \>18 years scheduled for unilateral TKA
Trial design
Case-control
Prospective
Treatments tested in this trial
Local Anesthetic Injection
Procedure/Surgerycombination of regional blocks for TKA postoperative analgesia
Treatment groups
Trial outcomes
Primary outcomes
Quality of Recovery (QoR-15) score at 24 hours post-surgery
Quality of Recovery (QoR-15) - score range 0-150 - higher scores indicate better recovery
Secondary outcomes
Postoperative pain scores (NRS) at rest and movement (0-48 hours)
NRS at rest and movement - score range 0 (no pain) - 10 (the worst pain)
Time to first mobilization
first patient mobilization - time (hour) of first mobilization
Analgesic consumption (total drug dosage)
Effectiveness of the blocks
Time to first analgesic request (time - hour - of first request)
Duration of the blocks
Sponsors and contacts
Click on the lead sponsor to view all of their trials.